Katrin J Svensson

Dr. Svensson is an Associate Professor in the Department of Pathology at Stanford University, the Metabolic Core Director and Affinity Group Leader at the Stanford Diabetes Research Center (SDRC), an Arc Institute Innovation Investigator, and a Weill Cancer Hub West Investigator. Her laboratory studies the physiology and biochemistry of circulating factors and peptide hormones by using a combination of computational, proteomics, cellular, and physiological approaches. Dr. Svensson is the recipient of the Richard E. Weitzman Outstanding Early Career Investigator Award (Endocrine Society, 2026), the Arc Institute Innovation Investigator Award (2025), the Weill Cancer Hub West Investigator Award (2025), and the Alba Tull Molecular Therapeutics Award for Innovative Medicines (2024). Dr. Svensson is a standing member of the NIDDK POMD study section, serves as an Associate Editor for Endocrine Reviews and is on the Editorial Board at Diabetes. She is also a co-founder of Merrifield Therapeutics. Her laboratory has been supported by grants from the NIH, American Heart Association, Innovative Medicines Accelerator, Wu Tsai Neuroscience, Weill Cancer Hub, SPARK, SDRC, MCHRI, Merck, Eli Lilly, and Pfizer.